Current anti-copper therapies in management of Wilson disease
In Wilson disease (WD) severity of disease can vary widely, depending on time of diagnosis. Early treatment can prevent the development of symptoms in patients. In all patients, lifelong medical treatment is indicated. Currently available medical regimens include the copper chelators for example D-p...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2019
|
| In: |
Annals of translational medicine
Year: 2019, Jahrgang: 7, Heft: S2 |
| ISSN: | 2305-5847 |
| DOI: | 10.21037/atm.2019.02.48 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.21037/atm.2019.02.48 Verlag: http://atm.amegroups.com/article/view/24683 
|
| Verfasserangaben: | Isabelle Mohr, Karl Heinz Weiss |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1679248928 | ||
| 003 | DE-627 | ||
| 005 | 20230426155223.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191021s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21037/atm.2019.02.48 |2 doi | |
| 035 | |a (DE-627)1679248928 | ||
| 035 | |a (DE-599)KXP1679248928 | ||
| 035 | |a (OCoLC)1341248327 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Mohr, Isabelle |d 1989- |e VerfasserIn |0 (DE-588)1188592181 |0 (DE-627)1667540092 |4 aut | |
| 245 | 1 | 0 | |a Current anti-copper therapies in management of Wilson disease |c Isabelle Mohr, Karl Heinz Weiss |
| 264 | 1 | |c 2019 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.10.2019 | ||
| 520 | |a In Wilson disease (WD) severity of disease can vary widely, depending on time of diagnosis. Early treatment can prevent the development of symptoms in patients. In all patients, lifelong medical treatment is indicated. Currently available medical regimens include the copper chelators for example D-penicillamine (DPA) or trientine (TETA), acting to increase copper excretion and zinc salts (ZS), which reduce copper uptake. In this chapter, we discuss considerations regarding choice of drug and safety limitations. | ||
| 700 | 1 | |a Weiss, Karl Heinz |d 1976- |e VerfasserIn |0 (DE-588)130069531 |0 (DE-627)489615465 |0 (DE-576)297980203 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of translational medicine |d Shatin, NT : AME Publishing Company, 2013 |g 7(2019,S2) Artikel-Nummer S69, 7 Seiten |h Online-Ressource |w (DE-627)886406072 |w (DE-600)2893931-1 |w (DE-576)488397944 |x 2305-5847 |7 nnas |a Current anti-copper therapies in management of Wilson disease |
| 773 | 1 | 8 | |g volume:7 |g year:2019 |g number:S2 |g extent:7 |a Current anti-copper therapies in management of Wilson disease |
| 856 | 4 | 0 | |u https://doi.org/10.21037/atm.2019.02.48 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://atm.amegroups.com/article/view/24683 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191021 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 130069531 |a Weiss, Karl Heinz |m 130069531:Weiss, Karl Heinz |d 910000 |d 910100 |e 910000PW130069531 |e 910100PW130069531 |k 0/910000/ |k 1/910000/910100/ |p 2 |y j | ||
| 998 | |g 1188592181 |a Mohr, Isabelle |m 1188592181:Mohr, Isabelle |d 910000 |d 910100 |e 910000PM1188592181 |e 910100PM1188592181 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1679248928 |e 3525772122 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"2019","dateIssuedKey":"2019"}],"language":["eng"],"note":["Gesehen am 21.10.2019"],"relHost":[{"language":["eng"],"disp":"Current anti-copper therapies in management of Wilson diseaseAnnals of translational medicine","physDesc":[{"extent":"Online-Ressource"}],"note":["Erscheint zweimal wöchentlich, 2013 vierteljährlich, Januar 2014 - Februar 2015 monatlich","Gesehen am 10.05.2017"],"origin":[{"dateIssuedDisp":"[2013]-","publisherPlace":"Shatin, NT","publisher":"AME Publishing Company"}],"title":[{"subtitle":"ATM : an open access journal covering all subspecialties of translational medicine","title":"Annals of translational medicine","title_sort":"Annals of translational medicine"}],"titleAlt":[{"title":"ATM"}],"part":{"text":"7(2019,S2) Artikel-Nummer S69, 7 Seiten","extent":"7","volume":"7","year":"2019","issue":"S2"},"type":{"media":"Online-Ressource","bibl":"periodical"},"name":{"displayForm":["the official publication of: Society of Translational Medicine (STM), Hong Kong"]},"pubHistory":["Vol 1, no 1 (April 2013)-"],"recId":"886406072","id":{"eki":["886406072"],"zdb":["2893931-1"],"issn":["2305-5847"]}}],"physDesc":[{"extent":"7 S."}],"name":{"displayForm":["Isabelle Mohr, Karl Heinz Weiss"]},"recId":"1679248928","id":{"eki":["1679248928"],"doi":["10.21037/atm.2019.02.48"]},"title":[{"title_sort":"Current anti-copper therapies in management of Wilson disease","title":"Current anti-copper therapies in management of Wilson disease"}],"person":[{"role":"aut","family":"Mohr","roleDisplay":"VerfasserIn","given":"Isabelle","display":"Mohr, Isabelle"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Weiss, Karl Heinz","given":"Karl Heinz","family":"Weiss"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a MOHRISABELCURRENTANT2019 | ||